查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808877

心臟肌鈣蛋白市場（按產品類型、按測試類型、按最終用戶、按國家和地區）—2025 年至 2032 年全球產業分析、市場規模、市場佔有率和預測

Cardiac Troponin Market, By Product Type, By Test Type, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年心臟肌鈣蛋白市場規模價值為 33.4512 億美元，2025 年至 2032 年的複合年成長率為 8.5%。

心肌肌鈣蛋白市場圍繞著測量血液中肌鈣蛋白水平的診斷檢測產品的生產和銷售。肌鈣蛋白是檢測心肌損傷的關鍵生物標記物，尤其是在心肌梗塞（心臟病發作）等情況下。心肌肌鈣蛋白（cTnI 和 cTnT）是心臟受損時釋放到血液中的蛋白質，因此是心臟事件的高度敏感和特異性指標。心血管疾病 (CVD) 盛行率的上升、對早期準確診斷的需求不斷成長，以及高敏肌鈣蛋白檢測（hs-cTn 檢測）的進步，共同推動著該市場的發展。

這些檢測能夠更快發現心臟病發作，改善患者的預後。醫院、診斷實驗室和急診中心是主要的終端使用者。主要參與者包括雅培實驗室、羅氏診斷、西門子醫療和貝克曼庫爾特，他們透過創新和法規核准展開競爭。由於人口老化、久坐不動的生活方式以及人們對心臟健康的日益關注，市場正在擴大。然而，高昂的成本和嚴格的監管要求等挑戰也隨之而來。

心臟肌鈣蛋白市場-市場動態

緊急診斷中對高敏肌鈣蛋白檢測的需求不斷成長

心肌肌鈣蛋白市場的關鍵驅動力。這些先進的檢測方法甚至可以檢測血液中微量的肌鈣蛋白，與傳統檢測方法相比，能夠更早、更準確地診斷心臟病發作。急診室依靠高敏感肌鈣蛋白（hs-cTn）檢測快速確診或排除心肌梗塞，從而改善患者分診並減少不必要的住院。隨著全球心血管疾病（CVD）的發生率不斷上升，快速且精準的診斷對於獲得更好的治療效果至關重要。高敏感性檢測方法可以更快地做出決策，尤其是在症狀可能不明確的非ST段抬高型心肌梗塞（NSTEMI）病例中。高敏肌鈣蛋白檢測方法的監管批准以及相關指南的建議使用，進一步推動了市場的成長。

醫院和診斷實驗室擴大採用這些檢測來提高急診護理的效率。因此，領先的診斷公司正在投資下一代高敏感性肌鈣蛋白（hs-cTn）檢測，推動心肌肌鈣蛋白市場的創新和競爭。隨著醫療保健系統優先考慮更快、更可靠的心臟診斷，預計這一趨勢將持續下去。

心臟肌鈣蛋白市場-關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 8.5%。

根據產品類型細分，高敏感性心肌肌鈣蛋白 (hs-cTn) 檢測預計將在 2024 年佔據最大市場佔有率

根據檢測類型細分，肌鈣蛋白 I 檢測是 2024 年領先的檢測類型

根據最終用戶細分，醫院和急診室是 2024 年的主要最終用戶

從地區來看，北美是 2024 年最大的收入來源

心臟肌鈣蛋白市場-細分分析：

全球心臟肌鈣蛋白市場根據產品類型、測試類型、最終用戶和地區進行細分。

根據產品類型，市場分為三類：高敏感度心肌肌鈣蛋白檢測、常規心肌肌鈣蛋白檢測和即時診斷心肌肌鈣蛋白檢測。高敏感度心肌肌鈣蛋白 (hs-cTn) 檢測因其在心肌梗塞早期準確診斷中的卓越臨床實用性，在心肌肌鈣蛋白市場佔據主導地位。與常規檢測相比，這些先進的檢測方法可以檢測到血液中明顯較低的肌鈣蛋白水平，使醫生能夠更快地識別心臟損傷，通常在症狀出現後 1-2 小時內即可發現。這種快速檢測在緊急情況下至關重要，及時介入可以改善患者預後並降低死亡率。

臨床指引（例如ESC和ACC建議）優先將hs-cTn檢測用於診斷急性冠狀動脈症候群，這進一步鞏固了hs-cTn檢測的主導地位。醫院和實驗室擴大採用這些檢測，因為它們可以降低診斷不確定性，最大​​限制地減少不必要的住院，並提高工作流程效率。此外，羅氏、雅培和西門子等領先的診斷公司大力投資高靈敏度檢測，推動創新和市場滲透。

根據檢測類型，市場分為兩類：肌鈣蛋白 I 和肌鈣蛋白 T。肌鈣蛋白 I (cTnI) 在心肌肌鈣蛋白檢測領域佔據主導地位，佔據全球最大市場。這種優勢源自於幾個關鍵優勢：cTnI 檢測表現出卓越的心臟特異性，因為肌鈣蛋白 I 僅在心肌中表達，而肌鈣蛋白 T 則與骨骼肌的交叉反應性較小。雅培實驗室和貝克曼庫爾特等主要診斷公司已在 cTnI 檢測方面投入巨資，雅培的高敏肌鈣蛋白 I 檢測已成為美國和歐洲市場的領導者。

cTnI 細分市場的成長得益於其在急性冠狀動脈綜合症臨床指引和標準化診斷方案中的廣泛應用。與肌鈣蛋白 T（主要由羅氏專有的 Elecsys 平台控制）不同，肌鈣蛋白 I 檢測試劑來自多家製造商，這使得市場競爭更加激烈。此外，cTnI 檢測在某些患者群體（包括腎病患者）中表現出更佳的分析性能。雖然肌鈣蛋白 T 仍然很重要（尤其是在羅氏主導的市場中），但肌鈣蛋白 I 的心臟特異性、多供應商供應以及與不斷發展的高靈敏度檢測要求的契合度，鞏固了其作為現代心臟護理首選生物標記的地位。

心臟肌鈣蛋白市場-地理洞察

北美心肌肌鈣蛋白市場在全球佔據主導地位，這得益於其先進的醫療基礎設施、較高的心血管疾病患病率以及高敏肌鈣蛋白 (hs-cTn) 檢測的快速普及。美國憑藉其強大的報銷政策、FDA 對先進檢測的批准以及在急診室的廣泛應用，佔據領先地位。

加拿大緊隨其後，加大了對心臟護理的投入，並制定了標準化指南來推廣高敏肌鈣蛋白（hs-cTn）檢測。雅培、羅氏和西門子等主要診斷公司在該地區擁有強大的影響力，促進了競爭和創新。嚴格的監管標準確保了高品質的診斷，而人們對早期心臟病發作檢測意識的不斷提高也進一步刺激了需求。該地區對精準醫療和人工智慧整合診斷的關注將繼續推動市場成長。

心臟肌鈣蛋白市場-競爭格局：

心肌肌鈣蛋白市場的競爭格局以全球診斷巨頭之間的激烈競爭為特徵，其驅動力包括創新、法規核准和策略合作。雅培實驗室、羅氏診斷和西門子醫療憑藉其先進的高敏肌鈣蛋白 (hs-cTn) 檢測技術和強大的終端用戶網路，佔據市場主導地位。這些公司在準確性、速度和臨床實用性方面展開競爭，其中羅氏的 Elecsys Troponin T 和雅培的 Architect STAT hs-Troponin-I 在應用方面處於領先地位。

QuidelOrtho、bioMerieux 和 Beckman Coulter 等中型企業專注於利基市場，例如即時檢驗 (POCT) 和自動化實驗室系統；而 Randox Laboratories 和 Getein Biotech 等新興企業則瞄準成本敏感型市場，提供價格實惠的替代方案。併購活動（例如 Quidel 與 Ortho Clinical Diagnostics 的合併）正在重塑市場格局，提陞技術能力。

最新動態：

2024 年 6 月，雅培實驗室 (Abbott Laboratories) 獲得 FDA 批准，可在 Alinity ci 系列分析儀上進行下一代高靈敏度肌鈣蛋白 I 檢測，從而能夠在美國醫院更快地進行 MI 診斷。

目錄

第1章：心臟肌鈣蛋白市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 心臟肌鈣蛋白市場片段（依產品類型）
    • 心臟肌鈣蛋白市場片段（依測試類型）
    • 心臟肌鈣蛋白市場片段（按最終用戶）
    • 心臟肌鈣蛋白市場（按國家/地區）
    • 心臟肌鈣蛋白市場（按地區）
  • 競爭洞察

第3章：心臟肌鈣蛋白主要市場趨勢

  • 心臟肌鈣蛋白市場促進因素
    • 市場促進因素的影響分析
  • 心臟肌鈣蛋白市場限制
    • 市場限制的影響分析
  • 心臟肌鈣蛋白的市場機會
  • 心臟肌鈣蛋白市場未來趨勢

第4章：心臟肌鈣蛋白產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：心臟肌鈣蛋白市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：心臟肌鈣蛋白市場格局

  • 2024年心臟肌鈣蛋白市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：心臟肌鈣蛋白市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 高敏感度心肌肌鈣蛋白檢測
    • 常規心臟肌鈣蛋白檢測
    • 即時肌鈣蛋白檢測

第 8 章：心臟肌鈣蛋白市場 - 依測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 肌鈣蛋白I
    • 肌鈣蛋白T

第9章：心臟肌鈣蛋白市場－按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和急診科
    • 診斷和臨床實驗室
    • 門診手術中心
    • 其他

第 10 章：心臟肌鈣蛋白市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美心臟肌鈣蛋白主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲心肌肌鈣蛋白主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區心臟肌鈣蛋白主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲心臟肌鈣蛋白主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的心臟肌鈣蛋白主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：心臟肌鈣蛋白產業主要供應商分析

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Beckman Coulter
    • bioMerieux
    • Thermo Fisher Scientific
    • QuidelOrtho
    • Becton Dickinson
    • Sysmex Corporation
    • PerkinElmer
    • Bio-Rad Laboratories
    • Fujirebio
    • DiaSorin
    • Randox Laboratories
    • Tosoh Corporation
    • Ortho Clinical Diagnostics
    • Merck KGaA
    • ELITechGroup
    • Getein Biotech
    • Response Biomedical

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5510

Cardiac Troponin Market size was valued at US$ 3,345.12 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The cardiac troponin market revolves around the production and sale of diagnostic tests that measure troponin levels in the blood, which are critical biomarkers for detecting heart muscle damage, particularly in conditions like myocardial infarction (heart attack). Cardiac troponins (cTnI and cTnT) are proteins released into the bloodstream when the heart is injured, making them highly sensitive and specific indicators of cardiac events. The market is driven by the rising prevalence of cardiovascular diseases (CVDs), increasing demand for early and accurate diagnosis, and advancements in high-sensitivity troponin assays (hs-cTn tests).

These tests enable faster detection of heart attacks, improving patient outcomes. Hospitals, diagnostic labs, and emergency care centers are the primary end-users. Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Beckman Coulter, who compete through innovation and regulatory approvals. The market is expanding due to aging populations, sedentary lifestyles, and growing awareness of cardiac health. However, challenges include high costs and stringent regulatory requirements.

Cardiac Troponin Market- Market Dynamics

Rising demand for high-sensitivity troponin tests in emergency diagnostics

Key driver of the cardiac troponin market. These advanced assays detect even minute levels of troponin in the blood, enabling earlier and more accurate diagnosis of heart attacks compared to conventional tests. Emergency departments rely on hs-cTn tests to quickly rule in or rule out myocardial infarction, improving patient triage and reducing unnecessary hospital admissions. With cardiovascular diseases (CVDs) on the rise globally, rapid and precise diagnosis is critical for better outcomes. High-sensitivity tests allow for faster decision-making, particularly in cases of non-ST-elevation myocardial infarction (NSTEMI), where symptoms may be ambiguous. Regulatory approvals for hs-cTn assays, along with guidelines recommending their use, further boost market growth.

Hospitals and diagnostic labs are increasingly adopting these tests to enhance efficiency in acute care settings. As a result, leading diagnostic companies are investing in next-generation hs-cTn tests, driving innovation and competition in the cardiac troponin market. This trend is expected to continue as healthcare systems prioritize faster, more reliable cardiac diagnostics.

Cardiac Troponin Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, High-Sensitivity Cardiac Troponin (hs-cTn) Tests were predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Troponin I Tests were the leading Test Type in 2024

Based on End-user segmentation, Hospitals & Emergency Departments were the leading end-users in 2024

Based on region, North America was the leading revenue generator in 2024

Cardiac Troponin Market- Segmentation Analysis:

The Global Cardiac Troponin Market is segmented on the basis of Product Type, Test Type, End-user, and Region.

The market is divided into three categories based on product type: High-Sensitivity Cardiac Troponin Tests, Conventional Cardiac Troponin Tests, and Point-of-Care Troponin Tests. The High-Sensitivity Cardiac Troponin (hs-cTn) Tests segment dominates the cardiac troponin market due to its superior clinical utility in early and accurate diagnosis of myocardial infarction. These advanced assays can detect significantly lower levels of troponin in the blood compared to conventional tests, enabling physicians to identify heart damage much sooner, often within 1-2 hours of symptom onset. This rapid detection is critical in emergency settings, where timely intervention improves patient outcomes and reduces mortality rates.

The dominance of hs-cTn tests is further reinforced by clinical guidelines (e.g., ESC and ACC recommendations) that prioritize their use for diagnosing acute coronary syndromes. Hospitals and labs increasingly adopt these tests because they reduce diagnostic uncertainty, minimize unnecessary hospital admissions, and enhance workflow efficiency. Additionally, leading diagnostic companies like Roche, Abbott, and Siemens heavily invest in high-sensitivity assays, driving innovation and market penetration.

The market is divided into two categories based on Test Type: Troponin I, Troponin T. Troponin I (cTnI) dominates the cardiac troponin test type segment, holding the largest market share globally. This dominance stems from several key advantages: cTnI tests demonstrate superior cardiac specificity since troponin I is expressed exclusively in cardiac muscle, unlike troponin T, which shows minor skeletal muscle cross-reactivity. Major diagnostic players like Abbott Laboratories and Beckman Coulter have heavily invested in cTnI assays, with Abbott's High-Sensitivity Troponin-I test becoming a market leader in the U.S. and Europe.

The cTnI segment's growth is further propelled by its widespread adoption in clinical guidelines and standardized diagnostic protocols for acute coronary syndromes. Unlike troponin T (which is largely controlled by Roche's proprietary Elecsys platform), troponin I assays are available from multiple manufacturers, creating a more competitive market landscape. Additionally, cTnI tests show better analytical performance in certain patient populations, including those with renal disease. While troponin T remains important (particularly in Roche-dominated markets), troponin I's cardiac-specific nature, multi-vendor availability, and alignment with evolving high-sensitivity testing requirements cement its position as the preferred biomarker in modern cardiac care.

Cardiac Troponin Market- Geographical Insights

The North American cardiac troponin market dominates globally, driven by advanced healthcare infrastructure, high CVD prevalence, and rapid adoption of high-sensitivity troponin (hs-cTn) assays. The U.S. leads due to strong reimbursement policies, FDA approvals for advanced tests, and widespread use in emergency departments.

Canada follows closely, with increasing investments in cardiac care and standardized guidelines promoting hs-cTn testing. Major diagnostic players like Abbott, Roche, and Siemens have a strong presence, fueling competition and innovation. Strict regulatory standards ensure high-quality diagnostics, while rising awareness of early heart attack detection further boosts demand. The region's focus on precision medicine and AI-integrated diagnostics will continue shaping market growth.

Cardiac Troponin Market- Competitive Landscape:

The competitive landscape of the cardiac troponin market is characterized by intense rivalry among global diagnostics giants, driven by innovation, regulatory approvals, and strategic partnerships. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate the market, leveraging their advanced high-sensitivity troponin (hs-cTn) assays and strong End-user networks. These players compete on accuracy, speed, and clinical utility, with Roche's Elecsys Troponin T and Abbott's Architect STAT hs-Troponin-I leading in adoption.

Mid-sized firms like QuidelOrtho, bioMerieux, and Beckman Coulter focus on niche segments, such as point-of-care testing (POCT) and automated lab systems, while emerging players like Randox Laboratories and Getein Biotech target cost-sensitive markets with affordable alternatives. Mergers and acquisitions (e.g., Quidel's merger with Ortho Clinical Diagnostics) are reshaping the market, enhancing technological capabilities.

Recent Developments:

In June 2024, Abbott Laboratories received FDA clearance for its next-gen High-Sensitivity Troponin-I assay on the Alinity ci-series analyzers, enabling faster MI diagnosis in U.S. hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC TROPONIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • bioMerieux
  • Thermo Fisher Scientific
  • QuidelOrtho
  • Becton Dickinson
  • Sysmex Corporation
  • PerkinElmer
  • Bio-Rad Laboratories
  • Fujirebio
  • DiaSorin
  • Randox Laboratories
  • Tosoh Corporation
  • Ortho Clinical Diagnostics
  • Merck KGaA
  • ELITechGroup
  • Getein Biotech
  • Response Biomedical

GLOBAL CARDIAC TROPONIN MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • High-Sensitivity Cardiac Troponin Tests
  • Conventional Cardiac Troponin Tests
  • Point-of-Care Troponin Tests

GLOBAL CARDIAC TROPONIN MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Troponin I
  • Troponin T

GLOBAL CARDIAC TROPONIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Emergency Departments
  • Diagnostic & Clinical Laboratories
  • Ambulatory Surgical Centers
  • Others

GLOBAL CARDIAC TROPONIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Troponin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Troponin Market Snippet by Product Type
    • 2.1.2. Cardiac Troponin Market Snippet by Test Type
    • 2.1.3. Cardiac Troponin Market Snippet by End-user
    • 2.1.4. Cardiac Troponin Market Snippet by Country
    • 2.1.5. Cardiac Troponin Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Troponin Key Market Trends

  • 3.1. Cardiac Troponin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Troponin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Troponin Market Opportunities
  • 3.4. Cardiac Troponin Market Future Trends

4. Cardiac Troponin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Troponin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Troponin Market Landscape

  • 6.1. Cardiac Troponin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Troponin Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. High-Sensitivity Cardiac Troponin Tests
    • 7.1.3. Conventional Cardiac Troponin Tests
    • 7.1.4. Point-of-Care Troponin Tests

8. Cardiac Troponin Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Troponin I
    • 8.1.3. Troponin T

9. Cardiac Troponin Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Emergency Departments
    • 9.1.3. Diagnostic & Clinical Laboratories
    • 9.1.4. Ambulatory Surgical Centers
    • 9.1.5. Others

10. Cardiac Troponin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Troponin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Troponin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac Troponin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Troponin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac Troponin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cardiac Troponin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. Beckman Coulter
    • 11.2.5. bioMerieux
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. QuidelOrtho
    • 11.2.8. Becton Dickinson
    • 11.2.9. Sysmex Corporation
    • 11.2.10. PerkinElmer
    • 11.2.11. Bio-Rad Laboratories
    • 11.2.12. Fujirebio
    • 11.2.13. DiaSorin
    • 11.2.14. Randox Laboratories
    • 11.2.15. Tosoh Corporation
    • 11.2.16. Ortho Clinical Diagnostics
    • 11.2.17. Merck KGaA
    • 11.2.18. ELITechGroup
    • 11.2.19. Getein Biotech
    • 11.2.20. Response Biomedical

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us